Ekso Bionics
Richmond, US · Founded 2012 · 108 employees on LinkedIn · 2 known investors
Find your way into Ekso Bionics
762 people in our graph share verified history with the Ekso Bionics team — schools, employers, funds. One of them is your warm intro.
Anthony Linunlockedknows Nathan Harding · together at University of California, Berkeley (overlapped)
×4knows the team · via Deutsche Bank
knows the team · via Bear Stearns
knows the team · via Carnegie Mellon University
×3knows the team · via University of California, Berkeley
knows the team · via Commonwealth University-Bloomsburg
Ekso Bionics develops wearable exoskeleton robotics used to help people with paralysis stand and walk, to augment worker physical capabilities, and to support rehabilitation and R&D. It serves medical/rehabilitation and industrial markets in the healthcare robotics and medical device category.
Founders & leadership
Ekso Bionics was founded in 2012 by Russ Angold and Nathan Harding.
RA
Russ AngoldinChief Technology Officer
NH
Nathan HardinginChief Executive Officer and PresidentNathan Harding began designing robots in 1989 at Carnegie Mellon University's Field Robotics Center, working under roboticists including Red Whittaker, John Bares, and Kevin Dowling. He has led teams across early-stage and public companies, serving as CEO and President of Ekso Bionics, which develops wearable exoskeleton systems for medical rehabilitation and industrial applications.
JF
John F. Glennprincipal financial and accounting officer
JP
Jack PeurachinCEO2018–2022
SD
Scott DavisinChief Executive OfficerScott Davis is CEO of Ekso Bionics, a developer of wearable exoskeleton robotics for mobility assistance and rehabilitation. He previously held executive leadership roles at Globalmatix, GetWireless, Sierra Wireless, and AirLink Communications.
JW
Jerome WonginChief Financial Officer
MS
Max Scheder-BieschininChief Financial Officer2010–2018Chief Financial Officer and Treasurer at Ekso Bionics, where he navigated the company's transition to public markets and raised over $150M in equity and grant funding. Earlier, he held leadership positions as founder of Barefoot Motors, President of ZAP, and Managing Director at Deutsche Bank and ING Barings, advising on cross-border M&A and corporate finance across Europe.
FM
Frank MoremaninChief Operating OfficerFrank Moreman is Chief Operating Officer at Ekso Bionics, a developer of wearable exoskeleton robotics for paralysis rehabilitation and industrial augmentation. He brings operational leadership experience including P&L responsibility, organizational restructuring, regulatory management, and global operations across manufacturing and product development.
CL
Charles LiNamed on SEC filing
WS
William ShawNamed on SEC filing
SS
Stanley SternNamed on SEC filing
JJ
Jason JonesinChief Operating Officer
Investors · 2
Reported raises · per SEC filings
Form D private placements$103.3M disclosed across 4 of 7 rounds · 2014–2026
▶$3.5MofferedFeb 2021 · 4 investors · BiotechnologyRule 506(b)
▶$3.5MofferedFeb 2021 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jack PeurachExecutive Officer, Director
- Steven ShermanExecutive Officer, Director
- John F. GlennExecutive Officer
- Marilyn HamiltonDirector
- William ShawExecutive Officer
- Stanley SternDirector
- Ted WangDirector
- Thomas SchreckDirector
- Jason JonesExecutive Officer
- Charles LiDirector
- Offering amount
- $3.5M
- First sale
- Feb 2021
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$5.2MofferedJun 2020 · 7 investors · BiotechnologyRule 506(b)
▶$5.2MofferedJun 2020 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John F. GlennExecutive Officer
- Charles LiDirector
- William ShawExecutive Officer
- Jack PeurachExecutive Officer, Director
- Stanley SternDirector
- Jason JonesExecutive Officer
- Ted WangDirector
- Thomas SchreckDirector
- Marilyn HamiltonDirector
- Steven ShermanExecutive Officer, Director
- Offering amount
- $5.2M
- Sales commissions
- $552.3K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Jun 2020
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$22.8MraisedDec 2014 · 157 investors · Other TechnologyRule 506(b)
▶$22.8MraisedDec 2014 · 157 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Russ AngoldExecutive Officer
- Marilyn HamiltonDirector
- Jack PeurachDirector
- Nathan HardingExecutive Officer, Director
- Max Scheder-BieschinExecutive Officer
- Thomas LoobyExecutive Officer
- Daniel BorenDirector
- Steven ShermanDirector
- Offering amount
- $30.3M
- Amount sold
- $22.8M
- Sales commissions
- $1.1M
- Proceeds to insiders
- $2.4M
- Placement agents
- Dinosaur Securities L.L.C., EDI Financial, Inc.
- First sale
- Nov 2014
- Incorporated
- Corporation, Nevada, 2012
- Federal exemptions
- 06b
▶$27.4MraisedJan 2014 · 200 investors · Other TechnologyRule 506(b)
▶$27.4MraisedJan 2014 · 200 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Max Scheder-BieschinExecutive Officer
- Daniel BorenDirector
- Russ AngoldExecutive Officer
- Steven ShermanDirector
- Frank MoremanExecutive Officer
- Nathan HardingExecutive Officer, Director
- Jack PeurachDirector
- Marilyn HamiltonDirector
- Offering amount
- $30.3M
- Amount sold
- $27.4M
- Minimum investment
- $5K
- Sales commissions
- $2.2M
- Proceeds to insiders
- $1.9M
- Placement agents
- Dinosaur Securities LLC, EDI Financial, Inc.
- First sale
- Jan 2014
- Incorporated
- Corporation, Nevada, 2012
- Federal exemptions
- 06b
▶$2.3MraisedJan 2014 · 8 investors · Other TechnologyRule 506(b)
▶$2.3MraisedJan 2014 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel BorenDirector
- Jack PeurachDirector
- Max Scheder-BieschinExecutive Officer
- Russ AngoldExecutive Officer
- Frank MoremanExecutive Officer
- Nathan HardingExecutive Officer, Director
- Marilyn HamiltonDirector
- Steven ShermanDirector
- Offering amount
- $2.3M
- Amount sold
- $2.3M
- First sale
- Jan 2014
- Incorporated
- Corporation, Nevada, 2012
- Federal exemptions
- 06b
▶$50.8MraisedJan 2014 · 110 investors · Other TechnologyRule 506(b)
▶$50.8MraisedJan 2014 · 110 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Nathan HardingExecutive Officer, Director
- Russ AngoldExecutive Officer
- Steven ShermanDirector
- Marilyn HamiltonDirector
- Max Scheder-BieschinExecutive Officer
- Daniel BorenDirector
- Jack PeurachDirector
- Frank MoremanExecutive Officer
- Offering amount
- $50.8M
- Amount sold
- $50.8M
- First sale
- Jan 2014
- Incorporated
- Corporation, Nevada, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Hypershell Global262 shared keywordsHypershell builds wearable exoskeletons that assist walking, hiking, climbing, and cycling by reducing physical exertion and heart rate over long distances and steep terrain. Its products target outdoor adventurers, hikers, and expedition guides, and it is presented as the first exoskeleton to undergo third-party validation of its performance claims.
German Bionic248 shared keywordsGerman Bionic develops wearable exoskeletons and smart power suits that use AI to assist workers with heavy lifting, prevent posture injuries, and improve workplace safety. The company serves industrial, logistics, healthcare, and airport operations sectors globally.
Hilti214 shared keywordsHilti manufactures and distributes power tools, software, fasteners, safety equipment, and support systems for the construction industry. The company serves contractors and construction professionals with products ranging from drilling and fastening tools to project management software and professional engineering services.
Companies competing with Ekso Bionics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Ekso Bionics do?
- Ekso Bionics develops wearable exoskeleton robotics used to help people with paralysis stand and walk, to augment worker physical capabilities, and to support rehabilitation and R&D. It serves medical/rehabilitation and industrial markets in the healthcare robotics and medical device category.
- Who founded Ekso Bionics?
- Ekso Bionics was founded by Russ Angold, Nathan Harding in 2012.
- Who are Ekso Bionics's investors?
- Ekso Bionics's investors include Emery Capital, Lockheed Martin Ventures.
- How much funding has Ekso Bionics raised?
- Ekso Bionics has disclosed $103.3M raised across 4 of its 7 known rounds.
- Where is Ekso Bionics headquartered?
- Ekso Bionics is headquartered in Richmond, US.